View in EDS HTML Full Text PDF Full Text

Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics.

Saved in:
Bibliographic Details
Title: Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics.
Authors: Feleus S; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands., van der Lee M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Roos RAC; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., de Bot ST; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Source: Therapeutic advances in rare disease [Ther Adv Rare Dis] 2023 Nov 08; Vol. 4, pp. 26330040231204643. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 9918557474706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2633-0040 (Electronic) Linking ISSN: 26330040 NLM ISO Abbreviation: Ther Adv Rare Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37955016
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Feleus+S%22">Feleus S</searchLink>; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Lee+M%22">van der Lee M</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Swen+JJ%22">Swen JJ</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Roos+RAC%22">Roos RAC</searchLink>; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Bot+ST%22">de Bot ST</searchLink>; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918557474706676%22">Therapeutic advances in rare disease</searchLink> [Ther Adv Rare Dis] 2023 Nov 08; Vol. 4, pp. 26330040231204643. <i>Date of Electronic Publication: </i>2023 Nov 08 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918557474706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2633-0040 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226330040%22">26330040 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Rare Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37955016
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/26330040231204643
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 26330040231204643
    Titles:
      – TitleFull: Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feleus S
      – PersonEntity:
          Name:
            NameFull: van der Lee M
      – PersonEntity:
          Name:
            NameFull: Swen JJ
      – PersonEntity:
          Name:
            NameFull: Roos RAC
      – PersonEntity:
          Name:
            NameFull: de Bot ST
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 11
              Text: 2023 Nov 08
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2633-0040
          Numbering:
            – Type: volume
              Value: 4
          Titles:
            – TitleFull: Therapeutic advances in rare disease
              Type: main
ResultId 1